August 12, 2021
Advance Online.png?ixlib=gatsbyFP&auto=compress%2Cformat&fit=max&rect=0%2C57%2C367%2C186&w=311&h=158)
Advance Online
New Dosing Available for SKYRIZI®
SKYRIZI® (risankizumab-rzaa) is now available in the U.S. as a single-dose injection for the treatment of adults with moderate-to-severe plaque psoriasis.
SKYRIZI® (risankizumab-rzaa) is now available in the U.S. as a single-dose injection for the treatment of adults with moderate-to-severe plaque psoriasis.
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.
